AmDen Pharmaceuticals played a vital role in bringing together two leading drug companies—Renexxion Ireland Ltd and Dr. Falk Pharma—in a strategic partnership focused on the development of a much-needed treatment for gastroparesis. Acting as the key facilitator, AmDen leveraged its deep industry expertise and strong global network to align the complementary strengths of both organizations.  Renexxion and Dr. Falk have now successfully enrolled over 320 patients in the global MOVE-IT Phase 2b study of naronapride for gastroparesis. This facilitation underscores the power of collaboration in accelerating clinical development and addressing unmet medical needs.